Medicine · bench card

Vigabatrin

https://shortagesignal.co.uk/medicine/vigabatrin

As of 01 Nov 2026 22:15 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2023/003 Tier 2 · issued 17 Jan 2023 (1384 days ago)

Expected backw/c 3rd March 2023 as stated in the latest recorded notice stated date passed — no update recorded (1333 days)window end 09 Mar 2023, derived from “w/c 3rd March 2023”

Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register

ScotlandMSAN(2023)5 issued 24 Jan 2023 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2023/003 (17 Jan 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

Presentation	Status, as stated	Expected back, as stated	Stated in
Vigabatrin (Sabril®) 500mg tabletsaffected product · inferred from phrasing	Out of stock, as stated	w/c 3rd March 2023precision: a month · window end 09 Mar 2023, derived from “w/c 3rd March 2023”	notice of 17 Jan 2023

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Vigabatrin

Also known as: Kigabeq 100mg soluble tablets · Kigabeq 500mg soluble tablets · Sabril 500mg granules for oral solution sachets · Sabril 500mg tablets · Vigabatrin 100mg soluble tablets sugar free · Vigabatrin 100mg/5ml oral solution · +8 more
BNF chemical: Vigabatrin 0408010X0 — matched on a generic name
Class: Control of epilepsy · Antiepileptic drugs · Central Nervous System
SNOMED codes: 12946611000001107, 12946911000001101, 12947211000001107, 12947511000001105, 12947811000001108 and 18 more
Suppliers named in the NHSBSA dataset: A A H Pharmaceuticals Ltd · Alliance Healthcare (Distribution) Ltd · MSN Laboratories Europe Ltd · Orphalan UK Ltd · Sanofi · Special Order · +1 more (from the dataset, not from the notices)

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 17 Jan 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Issued	Notice	Kind	Tier	Reference
17 Jan 2023	Medicine Supply Notification: Vigabatrin (Sabril®) 500mg tablets	Supply notification	Tier 2	MSN/2023/003

Also recorded under

Bracketed names seen in this medicine's notice titles: sabril. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

MSAN(2023)5 Vigabatrin (Sabril®) 500mg tablets · issued 24 Jan 2023 · valid until w/c 3rd of March 2023, as stated · matched by name PDF ↗